News Stories

Permanent pacemaker implantation after TAVR increases healthcare costs by $24,000 per patient

Implanting a permanent pacemaker (PPM) after transcatheter aortic valve replacement (TAVR) is costing health systems an average of more than $23,000 per patient, according to new findings published in Cardiovascular Revascularization Medicine. This includes the price of the device, the implant procedure and other costs not directly related to patient care.

CMS Mandate for Shared Decision-Making Didn’t Affect ICD Use

Use was already declining before the requirement, and continued to do so after it was implemented.

Biotronik’s DX devices reach 100,000-patient milestone

Biotronik has announced the milestone achievement of 100,000 implanted single-chamber implantable cardioverter-defibrillators (ICDs) equipped with DX Technology.

Element Science receives CE Mark for the Jewel patch-wearable cardioverter defibrillator

Element Science has announced that it has received CE mark certification and UK Conformity Assessed (UKCA) marking for its novel patch-wearable cardioverter defibrillator (P-WCD) from its notified body, the BSI Group.

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

The survival benefit of a cardiac resynchronization therapy-defibrillator (CRT-D) lasts for several years in patients with mild-to-moderate symptoms of heart failure (HF), a reduced ejection fraction, and a wide QRS complex, according to extended follow-up of the RAFT trial.